These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7673612)

  • 21. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
    Saniee P; Shahreza S; Siavoshi F
    Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR
    J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H
    Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I; Fukuda Y; Okui M; Tamura K; Shimoyama T
    J Clin Gastroenterol; 1995; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
    Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M
    J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological therapy of Helicobacter pylori infection.
    Hoffman JS
    Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro susceptibilities of Helicobacter pylori strains from children to proton pump inhibitors and its thioether derivative].
    Taneike I; Tamura Y; Shimizu T; Yamashiro Y; Toyoda S; Yamamoto T
    Kansenshogaku Zasshi; 2000 Jul; 74(7):601-2. PubMed ID: 10965666
    [No Abstract]   [Full Text] [Related]  

  • 33. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polaprezinc].
    Kuwayama H; Takahashi M; Suzuki K; Suga M; Takata H; Ohara T; Koizumi K; Kiriyama Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():717-20. PubMed ID: 11979877
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
    Tamura K; Murai M; Tanaka M; Kawano S
    Nihon Rinsho; 1993 Dec; 51(12):3261-6. PubMed ID: 8283644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method.
    Shimada T; Ogura K; Ota S; Terano A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S100-3. PubMed ID: 7594321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.